• New lipidomics data reports are now available

    As of May, we began rolling out our fully overhauled lipidomics data reports. After months of intensive work, the data science team incorporated many improvements – from clear design, to new analyses, reworked data structure, and much more.

    read more →

  • 6.55M fund for research on long-term effects of COVID-19

    It has been already more than two years since the world was shocked by COVID-19. With countless infections and deaths worldwide, there are cases reported regarding long-term effects in some patients.

    read more →

  • Lipotype goes to Seoul

    Lipotype is going to Seoul, South Korea!

    read more →

  • Lipotype Fundraiser Event

    We at Lipotype believe that human life and health are the highest values. In March we have purchased and sent 10.000 EUR worth of medical supplies and medications including defibrillators, first aid kits, wound dressing materials, medications for cardiovascular emergencies, and first-line medications for the people living with chronic diseases. These supplies have been delivered

    read more →

  • Lipotype goes to Boston

    As a proud sponsoring partner of the 10th Neurodegenerative Drug Development Summit (NDD) in Boston, Lipotype is attending this event from 28th to 30th March.

    read more →

  • A new publication

    As a pioneer in the field of lipidomics, Lipotype not only provides lipidomic analysis services to customers but also contributes to science through carrying out its own research.

    read more →

  • Newly launched blood plasma lipidomics package

    Lipotype launched new analysis packages for population health studies.

    read more →

  • The Lipidomics Webinar

    We all know that genes and proteins are important in biological research. But what about lipids? Lipidomics has proven its usefulness in many studies, but still a lot of scientists do not know about lipidomics and have no clear picture of how it will benefit their research. Hence, we newly launched a webinar series, The

    read more →

  • Turning crisis into progress.

    Even in the midst of a global crisis, COVID-19, there are people who try to make the best of it.

    read more →

  • Diversity Statement

    As biotechnology and pharmaceutical research organizations, we seek to cure diseases, improve health, and secure a better future for everyone in society. Our ability to carry out this important work depends on diversity and internationalism. We stand no chance of succeeding unless we work together and embrace diversity.

    read more →